SUMMARY
synaptotagmin-1, Doc2a, and Doc2b and report that they differentially contribute to spontaneous excitatory and inhibitory release.
INTRODUCTION
Though evoked neurotransmitter release is the primary means of chemical communication between neurons, it is now clear that spontaneous release, occurring in the absence of action potentials, also plays a crucial role in synaptic structure and function. Spontaneous release modulates post-synaptic excitability by regulating the tonic activity of high-affinity receptors (Farrant and Nusser, 2005; Kombian et al., 2000) , or by directly shaping action potentials (Carter and Regehr, 2002) . Spontaneous release also suppresses post-synaptic protein synthesis (Sutton et al., 2004 , stabilizes dendritic spines (McKinney et al., 1999) , maintains receptor density in the post-synapse (Ehlers et al., 2007) , and mediates long-term forms of synaptic plasticity (Frank et al., 2006; Zhang et al., 2009) . Despite the physiological importance of this mode of transmission, the molecular mechanisms that regulate spontaneous fusion, and how these mechanisms differ from evoked release, remain unclear (Ramirez and Kavalali, 2011) . The majority of spontaneous release events are Ca 2+ dependent (Groffen et al., 2010; Xu et al., 2009 ). Previous studies have identified two putative intracellular Ca 2+ sensors that facilitate miniature events (minis): synaptotagmin-1 (syt1) ) and the cytosolic double C2-domain protein b (Doc2b) (Groffen et al., 2010) . Syt1, Doc2b, and another closely related Doc2 isoform, Doc2a, bind Ca 2+ and phospholipids via two tandem C2 domains; both Doc2 isoforms exhibit considerably slower membrane binding kinetics and higher affinities for Ca 2+ as compared to syt1 (Brose et al., 1992; Kojima et al., 1996; Groffen et al., 2006; Yao et al., 2011) . The finding that syt1 functions as a Ca 2+ sensor for spontaneous neurotransmission was based on experiments using a supra-physiological range of extracellular Ca 2+ (up to 10 mM), without examining whether or how this low-affinity sensor regulates spontaneous release at physiologically relevant [Ca 2+ ] . Furthermore, whether Doc2b is a direct Ca 2+ sensor or merely in the Ca 2+ -sensing pathway is controversial. Namely, it was reported that a Ca 2+ ligand mutant form of Doc2b, that was unable to bind Ca 2+ , was still able to rescue the decrease in mini frequency observed in Doc2b KO neurons (Pang et al., 2011) . However, specific Ca 2+ ligand mutations in Doc2 have been reported to result in constitutive activation of the protein (Groffen et al., 2006; Xue et al., 2015) . Whether this constitutive activity was present in the mutant utilized by Pang et al. (2011) was not examined. Thus, we reasoned that a thorough and direct comparison of wildtype (WT) and mutant versions of these sensors would yield valuable insights into the mechanisms regulating Ca 2+ -dependent spontaneous fusion.
Here, we recorded miniature events in Doc2a, Doc2b, and syt1 individual KO neurons and unexpectedly observed that the roles played by each of these proteins depended on whether minis were glutamatergic or GABAergic. This segregation was due, in part, to differential expression of Doc2 isoforms, and to distinct differences in how voltage-gated Ca 2+ channels influence spontaneous release from GABAergic versus glutamatergic neurons. Separately, we demonstrate that both Doc2a and Doc2b must be capable of binding Ca 2+ to drive spontaneous fusion. We reconcile these results with published data (Pang et al., 2011) by showing that a mutant previously used to suggest a Ca 2+ -independent role for Doc2b in spontaneous release is, instead, a gain-of-function mutation that mimics a Ca 2+ -bound state. Indeed, expressing this mutant form of Doc2b in KO neurons renders the majority of spontaneous release events Ca 2+ independent. We conclude that Doc2a, Doc2b, and syt1 function as direct Ca 2+ sensors that drive spontaneous fusion, and their distinct contributions to this form of transmission represent an unanticipated divergence in the release machinery between GABAergic and glutamatergic neurons.
RESULTS
Individual KO of Doc2a, Doc2b, and syt1 Differentially Affects Spontaneous Glutamate versus GABA Release To examine Ca
2+
-dependent regulation of spontaneous glutamate release, pharmacologically isolated AMPA-receptor-mediated miniature excitatory post-synaptic currents (mEPSCs) were recorded from cultured mouse hippocampal neurons in the presence of tetrodotoxin (TTX) (1 mM). Separately, pharmacologically isolated GABA A -receptor-mediated miniature inhibitory postsynaptic currents (mIPSCs) were also recorded in the presence of TTX. Acute removal of free Ca 2+ via the application of BAPTA-AM (30 mM) and cyclopiazonic acid (CPA, 30 mM) in Ca 2+ -free bath solution, which decreased the basal free [Ca 2+ ] in the presynaptic compartment from $50 to $30 nM ( Figure S1 ), reduced the frequency of mEPSCs by 87% ± 2% (n = 5; p = 0.003 paired t test; Figure 1A ) and mIPSCs by 86% ± 4% (n = 4; p = 0.03 paired t test; Figure 1B ). Thus, the majority of minis are regulated by Ca 2+ that presumably acts via Ca
-sensing proteins (Groffen et al., 2010; Xu et al., 2009) .
To determine the roles of the Ca 2+ sensors Doc2a, Doc2b, and syt1, we recorded from hippocampal mouse neurons lacking each of these proteins; WT littermates served as controls. Syt1 KO neurons exhibited an $3-fold increase in the frequency of both mEPSCs and mIPSCs, consistent with syt1's previously reported function as an inhibitory clamp of spontaneous fusion (mEPSCs: syt1 WT: 2.8 ± 0.5 Hz, n = 16; syt1 KO: 9.7 ± 1.2 Hz, n = 18, p < 0.001; mIPSCs: syt1 WT: 1.0 ± 0.2 Hz, n = 14; syt1 KO: 3.1 ± 0.6 Hz, n = 10; p < 0.001; Figures 1C and 1D) (Broadie et al., 1994; Chicka et al., 2008 , but see Liu et al., 2009 Wierda and Sørensen, 2014) . Loss of each of the two Ca 2+ sensitive Doc2 isoforms, a and b, had differential effects on mEPSC and mIPSC frequencies. In Doc2a knockout (KO) neurons, the frequency of glutamatergic mEPSCs was reduced by 56% (Doc2a WT: 3.5 ± 0.6 Hz, n = 17; Doc2a KO: 1.6 ± 0.3 Hz, n = 20; p = 0.002; Figure 1C ), while GABAergic mIPSCs were unchanged (Doc2a WT: 0.9 ± 0.2 Hz, n = 13; Doc2a KO: 1.1 ± 0.2 Hz, n = 11; p = 0.63; Figure 1D ). In contrast, Doc2b KO neurons had normal mEPSC frequencies (Doc2b WT: 3.1 ± 0.5 Hz, n = 19; Doc2b KO: 3.5 ± 0.5 Hz, n = 16; p = 0.57; Figure 1C ) but had $60% fewer mIPSCs (Doc2b WT: 1.0 ± 0.2 Hz, n = 15; Doc2b KO: 0.4 ± 0.1 Hz, n = 16; p = 0.003; Figure 1D) . In all cases, the loss of each respective Ca 2+ sensor did not affect the amplitude or shape of mEPSCs or mIPSCs, or the density of excitatory or inhibitory synapses ( Figure S2 ). As . (C) Representative traces (left) and quantification (right) of the effect of single KO of syt1 (orange), Doc2a (blue), and Doc2b (green) on mEPSC frequency compared to WT littermate controls. Syt1 KO resulted in an ''unclamped'' phenotype and an increase in mEPSC frequency, while Doc2a KO significantly reduced mEPSC frequency. Loss of Doc2b had no effect. (D) Same as (C), but examining mIPSCs. Syt1 KO again resulted in an ''unclamped'' phenotype, whereas Doc2b KO significantly reduced mIPSC frequency; loss of Doc2a had no effect. **p < 0.01; ***p < 0.001; n.s., p > 0.05. Bar graphs represent mean ± SEM. See also Figures S1 and S2.
previous reports have shown that KO of Doc2a and/or b does not alter synchronous release or the size of the readily releasable pool in neurons (Groffen et al., 2010; Yao et al., 2011) , these changes in mini frequencies are unlikely to be secondary to defects in vesicle docking/priming or deficiencies in synchronous release.
The observation that Doc2a regulates spontaneous glutamate release, while Doc2b regulates spontaneous GABA release, reveals an unexpected difference between excitatory and inhibitory neurons. In contrast, syt1 clamped both mIPSCs and mEPSCs. Whether syt1 also drives minis in response to Ca 2+ ] O ), estimated to be $1-2 mM for the mammalian brain (Jones and Keep, 1988) . In WT neurons, increasing [Ca 2+ ] O from 1.2 to 2.4 mM consistently increased the frequency of mEPSCs by $25% (syt1 WT: 26% ± 6%, n = 11, p = 0.002 paired t test; Doc2a WT: 20% ± 10%, n = 10, p = 0.028 paired t test; syt1 WT versus Doc2a WT: p = 0.61; Figures 2A-2C ). This Ca
-induced increase in mini frequency was unaffected by loss of syt1 (1.2 versus 2.4 mM Ca 2+ , syt1 KO: 25% ± 7% increase, n = 12, p = 0.037 paired t test; p = 0.85 versus syt1 WT; Figures 2A-2C) . We note that a prior report concluding that syt1 does trigger mEPSCs used a non-physiological range of [Ca 2+ ] O that extended up to 10 mM -dependent evoked release in KO neurons (Nishiki and Augustine, 2004 Figure S3 .
versus Doc2b WT: p = 0.60; Figures 2D-2F) . Surprisingly, both Doc2b and syt1 were required for this Ca 2+ -dependent increase in mIPSC frequency. Loss of Doc2b significantly reduced, but did not abolish, Ca 2+ -dependent spontaneous GABA release.
Syt1
KOs exhibited a similar effect on mIPSCs (1.2 versus 2.4 mM Ca 2+ ; syt1 KO: 7% ± 3% increase, n = 9, p = 0.014 paired t test; p = 0.037 versus syt1 WT; Doc2b KO: 5% ± 3% increase, n = 10, p = 0.024 paired t test; p = 0.031 versus Doc2b WT; -192/218-226 (Friedrich et al., 2010) . In C2B, loops 1 and 3 correspond to residues 284-291/296-303 and 345-353/357-365, respectively (Giladi et al., 2013 sensor for this form of exocytosis (Pang et al., 2011) . The pivotal experiment leading to this conclusion examined a mutant form of Doc2b in which six of the Ca 2+ -coordinating acidic residues (three in each C2 domain) were substituted with alanines to abolish Ca 2+ binding activity (here termed Figure 3B) ; these mutations include substitution of D220 in C2A. Importantly, it is well established that substitution of D220, either alone (Xue et al., 2015) or in combination with additional substitutions of other Ca 2+ -coordinating residues (Gaffaney et al., 2014; Groffen et al., 2006) , confers new functions and constitutive activity to Doc2b in terms of membrane binding and asynchronous release. Whether this D220 mutation confers constitutive activity regarding the regulation of spontaneous release, alone or in the context of the Doc2b-6x mutant (Pang et al., 2011) , has not been examined. We address this question below.
Upon binding Ca
2+ , Doc2a and -b translocate to the plasma membrane (Groffen et al., 2004) . Thus, translocation assays are widely utilized to characterize how mutations affect Ca 2+ -dependent membrane binding in native cellular environments. Here, WT and mutant versions of Doc2a and b were tagged with GFP at the C terminus and expressed in PC12 cells to visualize their subcellular distributions (Figures 3A and 3B) (Gaffaney et al., 2014; Groffen et al., 2006) . PC12 cells were used because presynaptic boutons are too small to monitor translocation. Both Doc2a-WT and Doc2b-WT localized primarily to the cytosol under control conditions (Doc2a-WT: 0.79 ± 0.04 PM/cyto, n = 12; Doc2b-WT: 0.83 ± 0.04 PM/cyto, n = 8, Figures 3C-3E ), as quantified by the ratio of the average GFP fluorescent intensity at the plasma membrane (PM), divided by the average intensity across the cytosol (termed PM/cyto, see Figure 3 and STAR Methods). As expected, both isoforms translocated to the PM upon treatment with ionomycin (ctrl versus 15 mM iono; Doc2a-WT: 1.88 ± 0.28 PM/cyto, n = 12, p = 0.001 paired t test; Doc2b-WT: 2.22 ± 0.47 PM/cyto, n = 8, p = 0.002 paired t test; Figures 3C-3E). Consistent with previous reports (Xue et al., 2015) , substitution of an asparagine for the Ca 2+ -coordinating residue D303 in Doc2b (Doc2b-D303N) completely disrupted Ca 2+ -dependent translocation (ctrl: 0.83 ± 0.04 PM/cyto, iono: 0.92 ± 0.07 PM/ cyto, n = 8, p = 0.17 paired t test, Figure 3 ). An analogous mutation to Doc2a (Doc2a-D291N) had the same disruptive effect (ctrl: 0.87 ± 0.04 PM/cyto, iono: 0.93 ± 0.05 PM/cyto, n = 9, p = 0.27 paired t test, Figure 3 ). In sharp contrast to these loss-of-function mutants, we found that the Doc2b-6x mutant (Pang et al., 2011) was constitutively localized to the PM under basal, unstimulated conditions (ctrl: 1.64 ± 0.05 PM/cyto, n = 11, p < 0.001 versus Doc2b-WT in Ctrl conditions, Figure 3 ), and did not further translocate in ionomycin (iono: 1.56 ± 0.06, n = 11, p = 0.11 versus ctrl). It was proposed that the gain of function exhibited by a similar set of Ca 2+ ligand mutations in Doc2b (D218,220N) was the result of an increase in Ca 2+ affinity, rather than true Ca 2+ -independent activity (Groffen et al., 2006) . However, as this 6x mutant was reported to not bind Ca 2+ at all (Pang et al., 2011) , it likely mimics the Ca 2+ -bound state.
We next expressed the untagged versions of these constructs in Doc2a or b KO neurons using lentivirus ( Figure S4 ) and tested whether they could rescue the mini frequency phenotypes. In Doc2a KO neurons ( Figure 4A ), expressing Doc2a-WT rescued the frequency of mEPSCs compared to GFP-expressing controls (GFP: 1.7 ± 0.3 Hz, n = 27; WT Doc2a: 3.7 ± 0.5 Hz, n = 37; p < 0.001; Figure 4B ). However, the Ca 2+ -ligand mutant Doc2a-D291N failed to rescue mEPSC frequency (Doc2a-D291N: 1.7 ± 0.2 Hz, n = 32; p = 0.99 versus GFP; Figure 4B) . Similarly, rescue of Doc2b KO neurons ( Figure 4C ) with Doc2b-WT restored mIPSC frequency (GFP: 0.4 ± 0.1 Hz, n = 11; WT Doc2b: 1.4 ± 0.2 Hz, n = 11; p < 0.001; Figure 4D ) while expression of Doc2b-D303N failed to restore mIPSC frequency (Doc2b-D303N: 0.5 ± 0.1 Hz, n = 9; p = 0.35 versus GFP; Figure 4D ). Thus, we conclude that Doc2a and b must interact with Ca 2+ to drive miniature release. This strongly (legend continued on next page)
implicates both isoforms as direct Ca 2+ sensors for spontaneous neurotransmission.
Finally, when Doc2b-6x was expressed in Doc2b KO neurons, mIPSCs were significantly more frequent than in Doc2b-WT expressing KO neurons (Doc2b-6x: 2.2 ± 0.2 Hz, n = 11; p < 0.001 versus GFP; p = 0.002 versus WT Doc2b; Figure 4D ). Furthermore, Doc2b-6x yielded mIPSCs that were largely independent of Ca 2+ (30 mM BAPTA-AM and 30 mM CPA in Ca 2+ -free bath) (Doc2b-WT, Ca 2+ -free: 0.1 ± 0.1 Hz, n = 5; Doc2b-6x, Ca 2+ -free: 1.4 ± 0.2 Hz, n = 6; p < 0.001; Figure 4E ). Roughly a third of these events were still Ca 2+ sensitive and were likely mediated by a distinct sensor (i.e., syt1 and perhaps other proteins such as the Ca 2+ -sensing GPCR; Vyleta and Smith, 2011) . These data, in agreement with the translocation data above, are consistent with the interpretation that the Doc2b-6x mutant is a gain-of-function variant that constitutively mimics the Ca 2+ -bound state of WT Doc2b.
Doc2a and -b Are Functionally Redundant, Differentially Expressed, and Localized to Synaptic Boutons
The observed neuronal subtype-specific mini phenotypes could result from differential expression patterns of Doc2a versus b or differences in their respective biochemical properties. Thus, we separately expressed either WT Doc2a or WT Doc2b under pan-neuronal promoters in Doc2a single-KO neurons to determine whether rescue of mEPSC frequency was isoform specific. Above, we demonstrated that WT Doc2a rescued the reduced frequency of mEPSCs observed in Doc2a KO neurons (Figure 4) . In parallel experiments, we found that WT Doc2b also rescued mEPSC frequency in Doc2a KO neurons (WT Doc2b: 2.9 ± 0.4 Hz, n = 16, ANOVA p = 0.002, p = 0.019 versus GFP, p = 0.29 versus WT Doc2a; Figure 5A ). Similar experiments in Doc2b single-KO neurons revealed that expression of either Doc2a or Doc2b equally rescued mIPSC frequency (WT Doc2a: 1.7 ± 0.2 Hz, n = 12, ANOVA p < 0.001, p < 0.001 versus GFP, p = 0.26 versus WT Doc2b; Figure 5B ). Because exogenous expression of either isoform could rescue the single-KO phenotype, it is likely that Doc2a and b are differentially expressed in glutamatergic versus GABAergic neurons. However, we have been unable to identify antibodies that can accurately label and differentiate endogenous Doc2a and Doc2b when controlled against single-and double-KO neurons (unpublished data). Therefore, we used RNAScope technology to examine the expression patterns of Doc2a and b mRNA in brain slices (10 mm thick, coronal) obtained from adult WT mice. We first examined the stratum pyramidale in the CA3 region of the hippocampus ( Figure 5C , top). This brain region is densely populated by glutamatergic pyramidal neurons; we observed very few GABAergic interneurons (visualized by VGAT mRNA staining; Figure 5C , middle), and those interneurons tended to be located just outside of the stratum pyramidale. In agreement with our functional data, we found that glutamatergic pyramidal neurons strongly expressed Doc2a-mRNA; Doc2b-mRNA puncta were occasionally, but rarely, detected ( Figure 5C middle and bottom). Next, to better observe the expression pattern of Doc2 isoforms in GABAergic neurons, we examined brain sections containing the dorsal striatum ( Figure 5D, top) . The dorsal striatum is densely populated by GABAergic neurons (>95% of total neurons; Figure 5D , middle) and is known to lack glutamatergic neurons altogether. Striatal GABAergic neurons strongly expressed Doc2b-mRNA while Doc2a-mRNA was largely absent ( Figure 5D , middle and bottom); we observed that <10% of neurons (7 out of 94) were positive for both Doc2 isoforms and that no striatal neurons only express Doc2a. Together, these data demonstrate that Doc2 isoforms are differentially expressed in excitatory and inhibitory neurons in these two regions of the adult mouse brain.
Due to technical limitations, the subcellular distribution of Doc2 protein in neurons remains an open question. The only evidence for synaptic localization stems from subcellular fractionation assays (Verhage et al., 1997) , where Doc2 was present in the synaptosomal PM and synaptic vesicle fractions. To localize Doc2 in living neurons, we generated C-terminal HaloTag fusion proteins of Doc2 isoforms ( Figures 6A and  6B ). For imaging experiments, the HaloTag fusion proteins were conjugated with JF646 HaloTag ligand dye ( Figure S5 ). Synaptic boutons were identified by transfection of mRubytagged synaptophysin. As cytosolic proteins, Doc2 fusion proteins were initially indistinguishable from volumetric markers, like monomeric GFP, that fill the cytosol when highly expressed in neurons ( Figure S6A ). So, we infected Doc2 KO hippocampal cultures with smaller lentiviral titers of the Doc2 HaloTag fusion constructs ( Figure S6A ). In these experiments, we observed a quantifiable enrichment of both Doc2a-HaloTag and Doc2b-HaloTag in many, though not all, of the synaptic boutons in the cognate KO neurons (Doc2a: enriched in 24% ± 4% of boutons, n = 5 fields of view/3 pups, p = 0.024 versus GFP; Doc2b: enriched in 24% ± 5% of boutons, n = 6 fields of view/3 pups, p = 0.012 versus GFP; Figures 6C  and 6D ). Importantly, cytosolic GFP that was co-infected alongside the Doc2-HaloTag fusion proteins was not similarly enriched at synapses when using lower viral titers ( Figures  6C and 6D) , and the Doc2-HaloTag signals (at low expression levels) were clearly above the background signal ( Figure S5) . Furthermore, the lower viral titers of both HaloTag fusion proteins fully rescued spontaneous release in corresponding KO neurons ( Figures S6B and S6C ), indicating that these proteins are functional at this expression level and that the HaloTag did not disrupt function or localization. Together, these observations indicate that Doc2a and Doc2b are enriched in synaptic boutons in living neurons. s.r., stratum radiatum; s.p., stratum pyramidale, s.o., stratum oriens. Scale bars (white) represent 50 mm and apply to all lower panels. Images were adjusted for brightness/contrast; corresponding channels underwent the exact same adjustments. RNAScope experiments were performed three times, on separate animals, and similar results were observed each time. White dashed lines were overlaid on the images to help highlight morphology. ***p < 0.001; *p < 0.05; n.s., p > 0.05. Bar graphs represent mean ± SEM. As with syt1, Doc2 exhibits Ca 2+ -dependent and -independent interactions with t-SNAREs and membranes (Kojima et al., 1996; Friedrich et al., 2008; Yao et al., 2011) . We employed biochemical approaches to evaluate the impact of the Doc2b D303N and 6x mutations on these interactions. We first examined membrane-binding activity using cosedimentation assays ( Figure 7A ). In the absence of Ca 2+ , increasing the mole fraction of phosphatidylinositol 4,5-bisphosphate (PIP 2 ) and phosphatidylserine (PS) caused a dose-dependent increase in membrane binding for syt1, Doc2b, and Doc2b-D303N ( Figures 7B and 7C ). This effect was strongly synergistic, as both PIP 2 and PS together were required for significant Ca 2+ -independent binding activity ( Figure 7C ). In contrast, Ca 2+ -independent lipid binding of Doc2b-6x was relatively strong in the presence of either PIP 2 or PS; again, a combination of these lipids exerted an additive effect on binding ( Figure 7C ). ] 1/2 for the mutant (WT: 47.3 ± 5.1 nM; D303N: 148 ± 12 nM; p < 0.001; Figure 7D ). The D303N mutation also significantly affected the Hill slope of the Ca 2+ curve (WT: 1.49 ± 0.16; D303N: 2.30 ± 0.38, Figure 7D ). Binding of the 6x construct under these conditions was not measured, as it is entirely membrane-bound in the Ca 2+ -free state under these conditions (Figures 7B and 7C) .
We next compared the t-SNARE-binding activities of the syt1 and Doc2b constructs using a HaloTag-based pull-down assay ( Figure 7E ). Purified HaloTag-C2AB fusion constructs were covalently linked to chloroalkane-bearing beads and used to pull down the t-SNARE heterodimer. Consistent with prior studies, this assay produced robust Ca 2+ -independent interactions between t-SNARE heterodimers and either syt1 or WTDoc2b, and these interactions were enhanced by the presence of Ca 2+ (EGTA versus Ca 2+ ; syt1: n = 5, p = 0.002; Doc2b: n = 5, p < 0.001; Figures 7F and 7G) . The D303N construct failed to exhibit a Ca 2+ -dependent increase in t-SNARE binding (n = 5, p = 0.52; Figure 7G ). As expected, the 6x construct also showed no Ca 2+ -dependent enhancement of t-SNARE binding (n = 5, p = 0.66; Figure 7G ). However, in contrast to its constitutive activity in cells, this 6x mutation did not enhance Ca 2+ -independent interactions with t-SNAREs (n = 5; 6x EGTA versus WT EGTA: p = 0.89; 6x EGTA versus WT Ca 2+ : p < 0.001). Thus, t-SNARE binding, when both Ca 2+ -dependent and -independent interactions are considered, did not correlate with the spontaneous release phenotype ( Figure 5 ). These results suggest that, while the D303N and 6x mutations may alter SNARE binding activity, changes in this interaction are not predictive of the ability of each construct to regulate spontaneous fusion. influx through voltage-gated calcium channels (VGCCs) inhibited spontaneous GABA but not spontaneous glutamate release (Tsintsadze et al., 2017) . As the Ca 2+ affinity of syt1 is considerably lower than Doc2, and VGCCs can be a source of relatively high [Ca 2+ ] signaling, we explored whether there might be a mechanistic relationship between mIPSCs promoted by the activity of both syt1 and VGCCs.
We found that fully blocking VGCCs with saturating cadmium (Cd 2+ , 200 mM) in WT neurons resulted in an $33% inhibition of mIPSCs (ctrl: 1.1 ± 0.3 Hz, Cd 2+ : 0.7 ± 0.2 Hz, n = 5, p = 0.039, paired t test; Figure 8A ) but had no effect on the frequency of mEPSCs (ctrl: 3.7 ± 0.6 Hz, Cd 2+ : 3.9 ± 0.6 Hz, n = 4, p = 0.53, paired t test, Figure 8A ). We repeated this experiment measuring mIPSCs in single-KO neurons and found that loss of Doc2b increased the sensitivity to Cd 2+ , resulting in a 63% ± 8% reduction in mIPSC frequency (ctrl: 0.5 ± 0.1 Hz, Cd 2+ : 0.2 ± 0.1 Hz, n = 5, p = 0.002, paired t test; Figures 8B-8D ), while loss of syt1 abolished this sensitivity altogether (ctrl: 3.1 ± 0.1 Hz, Cd
2+
: 3.0 ± 0.1 Hz, n = 4, p = 0.24, paired t test; Figures 8B-8D ). These data indicate that Ca 2+ influx through VGCCs selectively activates syt1 to drive spontaneous GABA release. The increase in Cd 2+ sensitivity observed in Doc2b KO neurons is likely attributable to a greater percentage of miniature events being driven by syt1 when Doc2b is absent. We conclude that Ca 2+ entry through spontaneously opening VGCCs can activate syt1 to drive miniature release of GABA, but not glutamate ( Figure 8E ). These results identify syt1 and its relationship to VGCCs as a key point of divergence in GABA and glutamate neurons.
DISCUSSION
In this study, we compared the roles of the Ca 2+ -sensing proteins syt1 and Doc2a/b in regulating Ca 2+ -dependent, (C) Quantification of C2AB-liposome cosedimentation in varying lipid compositions (n = 2-3 independent experiments). In syt1, WT, Doc2b WT, and Doc2b D303N, Ca
2+
-independent binding is minimal with liposomes containing either PS or PIP 2 but increases when both phospholipids are present. Doc2b 6x exhibits substantially greater Ca 2+ -independent binding to both PIP 2 and PS. action-potential-independent, spontaneous neurotransmitter release. Syt1 is a low-affinity Ca 2+ sensor that couples action-potential induced Ca 2+ entry to synchronous neurotransmitter release in both excitatory and inhibitory neurons (Chapman, 2008) . While a previous report concluded that syt1 is also a major Ca 2+ sensor for spontaneous release in both glutamatergic and GABAergic neurons , it is important to note that this conclusion was drawn from experiments conducted over a supra-physiological range of [Ca 2+ ] O (up to 10 mM). Here, we show that when experiments are limited to near-physiological [Ca 2+ ] O , syt1 promotes Ca 2+ -dependent minis in inhibitory, but not excitatory, neurons. In inhibitory neurons, we found that Ca 2+ influx through VGCCs was sufficient to activate syt1 and drive spontaneous release. This Ca 2+ influx may arise from the spontaneous opening of a single VGCC, which is sufficient to drive quantal release in some cases (Bucurenciu et al., 2010; Shahrezaei et al., 2006; Stanley, 1993) , or from the coordinated, yet still spontaneous, opening of several channels (Williams et al., 2012) . Therefore, we speculate that one-third of mIPSCs (i.e., the percentage sensitive to Cd 2+ ) are triggered by syt1, potentially via mechanisms similar to those mediating action potential dependent release. However, unlike syt1-dependent evoked release, which displays strong Ca 2+ cooperativity, had only a minor effect on mIPSC frequency, consistent with previous observations (Williams et al., 2012) . We note that only a fraction of total events are syt1 dependent ($30%) and the degree of cooperativity between [Ca 2+ ] O and syt1-independent spontaneous fusion events (i.e., the majority of mIPSCs) is unclear. Furthermore, it is unlikely that the [Ca 2+ ] profiles seen by syt1 during spontaneous and evoked release would be similar. Differences in these [Ca 2+ ] profiles may arise due to differences in the number of activated VGCCs during each distinct event (i.e., spontaneous VGCC opening versus action potential driven VGCC opening). Additionally, evoked and spontaneous release may occur at distinct sites within an active zone (Reese and Kavalali, 2016) . Different coupling distances between VGCCs and syt1, stemming from distinct release sites, would also cause differences in the corresponding [Ca 2+ ] profiles. Why VGCCs acting via syt1 did not influence mEPSCs from glutamatergic neurons-or at least why supra-physiological [Ca 2+ ] O was required for syt1 to contribute to mEPSC frequency (Figure S3 )-remains unclear. One potential explanation is that GABAergic terminals, in both hippocampal cultures and slices, have been reported to be more responsive to Ca 2+ and have larger depolarization-induced Ca 2+ influx than glutamatergic terminals (Verderio et al., 2004) . Thus, in glutamatergic neurons, the spontaneous opening of a single or even multiple VGCCs may not sufficiently elevate local [Ca 2+ ] to activate the relatively low-affinity sensor, syt1. Finally, loss of syt1 resulted in an ''unclamped'' phenotype in both inhibitory and excitatory neurons with the rate of minis increasing by $3-fold in both cases. These findings are consistent with syt1 being present on both glutamatergic and GABAergic synaptic vesicles. We also note that previous reports revealed that the clamping function of syt1 can be affected by non-cellautonomous mechanisms; the molecular basis for this latter observation remains unclear (Liu et al., 2009; Wierda and Sørensen, 2014) . The finding that syt1 drives only mIPSCs and not mEPSC, but clamps both forms of spontaneous release, further demonstrates that syt1 has distinct, separate roles in limiting and promoting fusion (Liu et al., 2014; Bai et al., 2016) .
In contrast to the dual functionality of syt1, Doc2 acts only as a positive regulator of spontaneous fusion. Surprisingly, we observed a difference in the regulation of excitatory and inhibitory minis: Doc2a regulated mEPSCs while Doc2b regulated mIPSCs. This apparent difference in the function of each isoform was not due to biochemical differences, because pan-neuronal expression of either isoform was sufficient to rescue spontaneous release in both excitatory and inhibitory neurons. While these data directly contradict a previous report that rescue of spontaneous frequency in Doc2a/b double-knockdown neurons was isoform dependent (Pang et al., 2011) , they are in agreement with the observation that exogenous Doc2b expression rescued glutamatergic mini frequency in Doc2a/b double-KO neurons (Groffen et al., 2010) . Furthermore, our RNAScope experiments found that glutamatergic pyramidal neurons in the CA3 region of the hippocampus predominately expressed Doc2a-mRNA, while GABAergic neurons in the striatum predominately expressed Doc2b-mRNA. This is consistent with a previous study examining the expression of Doc2a and b mRNA at the regional level of the rodent brain, which reported that Doc2b was the predominant isoform in brain regions that are primarily comprised of inhibitory neurons, such as the cerebellum and striatum, while Doc2a appeared to be the major isoform in the deeper layers of the cortex and the CA1/CA3 pyramidal layer of the hippocampus (Verhage et al., 1997) . Thus, the subtype-specific phenotypes observed in our electrophysiological experiments can be explained by differences in expression of Doc2 isoforms between excitatory and inhibitory neurons. Furthermore, the fact that differential expression was observed in brain slices from adult mice makes it likely that our functional data and conclusions, obtained from cultured neurons, translate into a better understanding of an intact nervous system. Why separate isoforms of Doc2 evolved to differentially regulate spontaneous release in discrete populations of neurons, however, remains an open question.
It is controversial whether Doc2 is a direct Ca 2+ sensor for miniature release (Groffen et al., 2010) or instead is merely a component of the Ca 2+ -sensing pathway without itself needing to bind Ca 2+ (Pang et al., 2011) . We believe that the current study resolves this controversy by demonstrating two key points: (1) that loss-of-function Ca 2+ -ligand mutants of Doc2 are unable to support spontaneous fusion and (2) that other Ca
-ligand mutations, such as the one employed by Pang et al. (2011) , cause a constitutive gain of function that activates Doc2 independent of Ca 2+ and drive Ca 2+ -independent minis when expressed in neurons. These findings suggest that Doc2 directly binds Ca 2+ to regulate minis. The fact that constitutively activated Doc2 (i.e., Doc2b-6x) drives substantial mini frequencies in the complete absence of Ca 2+ further supports the conclusion that Doc2 is a direct and immediate Ca 2+ sensor for spontaneous fusion; activating Doc2 by itself is sufficient to drive minis in the absence of any other form of Ca 2+ signaling. Moreover, we demonstrate, for the first time, that Doc2 is indeed enriched in synaptic boutons in living neurons, where it could directly regulate the fusion machinery. These results suggest that Doc2 is either sorted to or retained in synapses by an unknown mechanism. Synaptic enrichment of Doc2 may be simply explained by its ability to associate with the synaptic vesicle fusion machinery; however, Doc2 does not appear to be uniformly distributed across all synapses. This heterogeneous distribution leads to an intriguing hypothesis that spontaneous transmission from individual boutons may be additionally regulated by the degree of Doc2 enrichment at that bouton. This hypothesis fits emerging models that the propensity of individual synaptic boutons to participate in spontaneous release varies greatly among different axonal terminals (Reese and Kavalali, 2016) .
Having demonstrated that Doc2 is enriched in synapses, we turned to biochemical approaches to gain insights into its mechanism of action. Utilizing the loss-of-function mutant Doc2b-D303N and the constitutively active mutant Doc2b-6x, we found that the ability to associate with membranes best correlated with the ability of each mutant to regulate minis. The D303N mutant had impaired Ca 2+ -dependent membrane interactions and did not support minis, while the 6x mutant was constitutively associated with membranes in reconstituted biochemical assays and in cells and constitutively drove minis in the absence of Ca 2+ . We note a slight discrepancy between the biochemical and cell-based membrane interaction experiments using the D303N mutant. In response to Ca
, this mutant failed to translocate to the PM in cells but was still able to bind reconstituted membranes in vitro, albeit at a lower Ca 2+ affinity. We postulate that the C2A domain, unaltered in the D303N mutant, can still bind Ca 2+ and associate with membranes in biochemical assays, but for reasons that remain unclear this domain cannot drive efficient membrane association in native cell membranes. It is important to note that Ca 2+ binding specifically to the C2B domain, containing D303, is thought to be the crucial determinant for other cellular functions of Doc2 (Gaffaney et al., 2014; Xue et al., 2015) , while Ca 2+ binding by C2A appears to be somewhat dispensable (Giladi et al., 2013; Xue et al., 2015) . In short, Doc2 interactions with the PM, driven by Ca 2+ binding to C2B, is a crucial step in the regulation of miniature release. In contrast to membrane binding, Ca 2+ -triggered t-SNARE binding activity was a poor predictor of whether the D303N or 6X mutant functioned during minis. No correlation was observed between the abilities of these mutants to bind t-SNAREs and to drive spontaneous release. This observation is consistent with reports that in some syt1 variants, Ca 2+ -triggered SNARE binding activity did not coincide with the ability of these mutants to regulate fusion (Liu et al., 2014; Bai et al., 2016) . At present, the relevance of syt1-t-SNARE interactions remains unresolved (Bhalla et al., 2006; Tucker et al., 2004; Zhou et al., 2015; Guan et al., 2017; Zhou et al., 2017) . Unlike syt1, Doc2 did not to respond to Ca 2+ influx from VGCCs: mEPSCs in general, and mIPSCs in syt1 KO neurons, were unaffected by Cd
. As Doc2a and b are orders of magnitude more sensitive to Ca 2+ than syt1 (Brose et al., 1992; Kojima et al., 1996; Groffen et al., 2006; Gaffaney et al., 2014) and have markedly slower intrinsic kinetics (Yao et al., 2011) , these data support the hypothesis that Doc2 and syt1 translate distinct Ca 2+ signals, perhaps at distinct physical release sites, into spontaneous neurotransmission. We note similarities in our measurements for resting [Ca 2+ ] in the presynaptic compartment ($50 nM, Figure S1 ) and the [Ca 2+ ] 1/2 of in vitro Doc2-lipid interactions ($50 nM, Figure 7D ), suggesting that basal cytosolic [Ca 2+ ] may potentially be a source for Doc2 activation. A number of additional Ca 2+ sources have been proposed to contribute to spontaneous fusion, including: Ca 2+ influx via tonically active Trp channels (Shoudai et al., 2010) , release of Ca 2+ from intracellular stores (Llano et al., 2000) , and resting cytosolic calcium (Kaeser and Regehr, 2014; Xu et al., 2009) . Determining which sensors (e.g., syt1, Doc2a, Doc2b) decode Ca 2+ signaling from these various sources, and how these sources may differentially influence various neuronal populations, is an intriguing area for future study that may offer further insights into the mechanism and control of spontaneous neurotransmission.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: 
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cryosections obtained from healthy male and female adult WT mice (4-7 weeks old) that were never involved with prior procedures. Mice were housed and cared for by the staff of the University of Wisconsin Research Animal Resources Center at the WIMR Vivarium facility. Cell lines used for this study (HEK293T/17 and PC12 cells) were cultured as described in the relevant Methods Details section, and were not tested for authentication.
METHOD DETAILS Neuronal Cultures and Lentivirus
Hippocampal neuronal cultures were prepared from syt1 (Jackson Laboratory), Doc2a, and Doc2b-KO mice (Groffen et al., 2010) . Mice were maintained as heterozygous breeder pairs, and pups were used for cultures at postnatal day 0-1. All procedures were in accordance with the guidelines of the National Institutes of Health and approved by the Animal Care and Use Committee at the University of Wisconsin. For all recordings, WT littermates were used as controls. Briefly, hippocampi were dissected from mouse brain, digested for 20 min at 37 C in 0.25% trypsin-EDTA (GIBCO), mechanically dissociated, and plated at a density of $100,000 cells/cm 2 onto 12 mm glass coverslips (Carolina Biological Supply) coated with poly-D-lysine. Cultures were grown in Neurobasal A medium (GIBCO) supplemented with B27 (2%, GIBCO) and GlutaMAX (2 mM, GIBCO) and maintained at 37 C in a 5% CO 2 humidified incubator.
For experiments involving lentivirus, DNA sequences encoding full-length WT Doc2a, Doc2a mutants, WT Doc2b, Doc2b mutants, WT syt1, and syt1 mutants were subcloned into a FUGW transfer plasmid (Lois et al., 2002) modified with a synapsin promoter and an IRES-expressed soluble eGFP marker. Lentiviral particles were generated by co-transfection of the transfer plasmid and helper plasmids (pCD/NL-BH*DDD and VSV-G encoded in pLTR-G) (Kutner et al., 2009 ) into HEK293T/17 cells. HEK293T/17 cells were grown in DMEM (GIBCO) supplemented with 10% FBS (Atlanta Biological) and penicillin/streptomycin, passaged when they were $90% confluent via trypsinization, and utilized only for their first 20 passages. Following transfection, the supernatant was collected after 48-72 hr of expression, filtered through a 0.45 mm PVDF filter, and concentrated by ultra-centrifugation at 110,000 x g for 2 hr (Kutner et al., 2009 ). Viral particles were re-suspended in Ca 2+ /Mg 2+ -free PBS and used to infect neurons at day-in-vitro (DIV) 6. Successful infection and expression was monitored by live-cell imaging of the co-expressed GFP and by immunocytochemistry (please see below for detailed methods) comparing GFP expression (Abcam, rabbit, 1:1000) against a neuronal marker, MAP2 (Millipore, chicken, 1:1000). By this measure, greater than 95% of neurons were infected in all experiments.
For Ca 2+ -imaging experiments, murine hippocampal neurons were cultured on 18 mm #1.5 coverslips and transfected at 5 DIV with a presynaptic fluorescent Ca 2+ indicator, syp-GCaMP6s, by calcium phosphate precipitation. Syp-GCaMP6s was generated by appending GCaMP6s to the C terminus of synaptophysin using a 14-residue linker [GS(GSS) 4 ] linker and expressed under an EF1a promoter (Matsuda and Cepko, 2004) .
Electrophysiology
Whole-cell voltage-clamp recordings were carried out using a Multiclamp 700B amplifier (Molecular Devices) at 16-19 DIV. Recordings were made at room temperature in a bath solution containing (in mM): 128 NaCl, 5 KCl, 1.2 CaCl 2 , 1 MgCl 2 , 30 D-glucose and 25 HEPES, pH 7.3 and 305 mOsm. Where indicated, CaCl 2 was increased to 2.4 or 10 mM. Patch pipettes (3 -5 MU) were pulled from borosilicate glass (Sutter Instruments). When recording mEPSCs, the pipette internal solution contained (in mM): 130 K-Gluconate, 1 EGTA, 10 HEPES, 2 ATP, 0.3 GTP, and 5 sodium phosphocreatine, pH 7.35 and 275 mOsm. When recording mIPSCs, KCl was used instead of K-Gluconate at the same concentration. Data were acquired using a Digidata 1440A (Molecular Devices) and Clampex 10 software (Molecular Devices) at 10 kHz. Neurons were held at À70 mV. Series resistance was compensated and recordings were discarded if the access resistance rose above 15 MU at any point. Tetrodotoxin (TTX, 1 mM, Abcam) was included in the bath solution to isolate miniature events. When recording mEPSCs, AMPA-receptors were pharmacologically isolated with D-AP5 (50 mM, Abcam) and picrotoxin (100 mM, Abcam). When recording mIPSCs, GABA A receptors were pharmacologically isolated with D-AP5 (50 mM, Abcam) and CNQX (20 mM, Abcam). Recorded traces were analyzed using Clampfit 10 (Molecular Devices). Where applicable, pharmacological agents were applied via bath perfusion (1-2 mL/min flow rate, 0.75 mL total bath volume, typically applied for 5-20 min until a constant effect was observed).
PC12 Cell Culture, Transfection, and Translocation Assays PC12 cells were cultured on 18 mm glass coverslips (Warner Instruments) coated with poly-D-lysine and collagen IV. Cells were grown in DMEM (GIBCO) supplemented with 5% FBS (Atlanta Biological) and 5% horse serum (Atlanta Biological) and maintained at 37 C in a 10% CO 2 humidified incubator. One day before imaging experiments, each coverslip was transfected with 2.5 mg of DNA using Lipofectamine LTX (Invitrogen). For these experiments, DNA sequences encoding full-length WT and mutant forms of Doc2a and b were subcloned into a pEF vector (Matsuda and Cepko, 2004) and were tagged at the C terminus with a flexible linker (GS-(GSS)x4) followed by eGFP. At 24 hr following transfection, coverslips were transferred to an imaging chamber and bathed in an imaging solution containing (in mM): 145 NaCl, 2.8 KCl, 2 CaCl 2 , 1 MgCl 2 , 10 D-glucose and 10 HEPES, pH 7.3 and 305 mOsm. Cells were imaged using an Olympus FV1000 confocal microscope and a 20x/1.0 numerical aperture (NA) objective before and after stimulation by the addition of ionomycin (15 mM final concentration) to monitor the subcellular localization of the GFP-tagged protein. Line scan analysis was performed on individual cells before and after treatment with ionomycin using ImageJ 1.50b software (NIH). PMs were visually identified as the edge regions adjacent to the background intensity and the cytosol intensity was defined as average intensity of the region between the PM at opposite ends of each cell. For each cell analyzed, the location of the line scan was the same for the control and stimulated images.
Live Cell Imagining of Doc2-HaloTag Fusion Proteins
The HaloTag ligand, JF 646 , was generously supplied by the Lavis Lab (HHMI, Janelia Research Campus). Neuronal cultures were incubated in 50nM JF 646 for 30 min to fluorescently label the Doc2-HaloTag fusion proteins. These cultures were then washed once and imaged in a solution of 140 mM NaCl, 5 mM KCl, 2 mM CaCl2, 2 mM MgCl 2 , 10 mM HEPES, and 10 mM glucose (pH 7.4). Images of live hippocampal cultures were acquired at room temperature using an Olympus FV1000 laser scanning confocal microscope, with PMT-based detection and a 20x/1.0NA water objective lens. All images were acquired with Olympus Fluoview software using identical laser and gain settings. Figure images were colored and smoothed in ImageJ. For clarity, the brightness and contrast of the images in Figures 7C and 7D were adjusted and these same adjustments were applied to the corresponding images of control cultures in Figures S4 and S5 .
For image quantification, synaptic boutons were identified by the presence of synaptophysin-mRuby3. The synaptophysin channel was thresholded to puncta and regions of interest (ROIs) were identified in ImageJ (Particle Analysis, 5-15 pixel ROIs). For Doc2 or GFP channels, a mean-filtered image (3 pixel radius of filtering) was subtracted from the raw image to detect local enrichment of either protein. Puncta were then identified by thresholding. Synapses, i.e., the ROIs identified in the synaptophysin channel, were considered to be positive for either GFP or Doc2 if they had a greater than 21% overlap with GFP or Doc2 puncta.
Presynaptic Ca 2+ Measurements
Images of live hippocampal cultures were acquired at room temperature using an Olympus IX81 inverted microscope with a 60X 1.45 NA oil-immersion objective. Illumination was provided by a 300W xenon arc lamp (Lambda DG-4, Sutter) attenuated with the DG-4's on-board neutral density filter function. Excitation and emission filtering were achieved with a standard GFP filter set (49002, Chroma) and images were acquired using a sCMOS camera (Orca FLASH 4.0 v2+, Hamamatsu) with 2x2 binning. Images were acquired using Micro-Manager 1.4 (Open Imaging) software (Edelstein et al., 2010) . Image analysis was performed in ImageJ. For each measurement, a Z stack (4 um, 0.4 um/slice) was acquired and collapsed by maximum projection. At 13-14 DIV, coverslips expressing syp-GCaMP6s were placed in same bath solution used for electrophysiological experiments, transferred to an imaging chamber (Warner), and allowed to equilibrate at room temperature for 5-10 min. After acquiring a baseline measurement, the bath solution was exchanged for a similar bath containing 0 mM Ca 2+ , 30 mM BAPTA-AM, and 30 mM CPA. Neurons were allowed to rest for 20 min before image acquisition under these conditions.
Single-wavelength Ca 2+ indicators require in situ calibration to account for the total indicator present in a given measurement. After imaging in the 0 mM Ca 2+ /BAPTA/CPA condition, the bath was exchanged for normal bath solution containing 4 mM Ca 2+ and 30 mM ionomcyin to saturate Syp-GCaMP6s. After 5 min, a final stack was acquired. For analysis, 5-pixel (1.0 mM) diameter round ROIs (30-90 per field of view) were selected and their intensities were measured using ImageJ. A dark region of the field of view was used for background subtraction. For each field of view, the value obtained after ionomycin treatment was used to obtain F max for use in the rearranged Hill equation (de Juan-Sanz et al., 2017) :
where K d is the dissociation constant of the indicator, F syp is the average fluorescence across all ROI's in the field of view, R f is the dynamic range of the indicator, and n is the Hill coefficient. For K d, R f , and n, we used published in vitro measurements (Chen et al., 2013) , allowing for a modest ($15%) reduction in R f to account for increased background and the imperfect overlap of ROIs with Syp-GCaMP6s signals at boutons. The [Ca] at a synapse was calculated using this equation for the baseline condition and after incubation with 0 mM Ca 2+ /BAPTA/CPA.
Immunoblotting
Cell lysates were prepared by dissolving single neuronal coverslips in boiling lysis buffer (100 mM Tris-Cl, 200 mM DTT, 4% w/v SDS, 0.2% w/v bromophenol blue, 20% v/v glycerol, pH 6.8). Samples were run on a 4%-12% NuPAGE Bis-Tris gradient gel (Invitrogen) and transferred to a nitrocellulose membrane (GE) for blotting. Blots were probed with an anti-synaptotagmin 1 antibody (mouse, 1:500, 48.1) and an anti-VCP antibody (mouse monoclonal, 1:1000, Abcam). Blots were visualized with HrP-conjugated secondary antibodies (goat anti-mouse IgG, 1:5000, Biorad). VCP was used as a loading control. Blots were imaged using an Amersham Imager 600 (GE) and brightness/contrast was adjusted for publication in ImageJ.
Immunocytochemistry Dissociated hippocampal neurons, cultured from either WT, syt1 KO, Doc2a KO, or Doc2b KO pups, were fixed with 4% paraformaldehyde in PBS, at 37 C, for 15 min. Fixed neurons were washed two times with PBS and then permeabilized, at RT, for 10 min in PBS using ImageJ. Ca 2+ titrations were performed similarly, with the substitution of BAPTA (3 mM) for EGTA. CaCl 2 additions to achieve the desired free [Ca 2+ ] were calculated using the WebMaxC Standard application (https://web.stanford.edu/$cpatton/ webmaxcS.htm).
HaloTag SNARE-Binding Assays Purified His 6 -Halo-C2AB constructs (100 mg) were combined with HaloLink resin (100 mL bed volume), and the mixture was brought up to 500 mL with binding buffer (150 mM KCl, 25 mM HEPES pH 7.4, 1% Triton X-100) and incubated 30 min at room temperature with rotation. Complete depletion of Halo-C2AB from the supernatant under these conditions was verified by SDS-PAGE. Halo-C2AB-bearing beads were washed 3x in binding buffer and resuspended as a 50% slurry. Forty mL of this slurry was added to a 150 mL binding reaction containing 2.5 mM t-SNAREs, 1 mM EGTA ± 1.5 mM Ca
2+
, and 1 mM DTT in binding buffer, and the mixture was incubated for 1 hr at room temperature. The beads were then washed 3x in binding buffer containing 1 mM EGTA ± 1.5 mM Ca 2+ , and the t-SNAREs were eluted in 35 mL 2x SDS sample buffer. For each sample, 15 mL of the eluate was subject to SDS-PAGE, the gels were imaged after staining with Coomassie Blue, and the band intensities quantified in ImageJ with background subtraction and normalization to a heterodimer loading control in each gel. For each gel, 2 mg of each His 6 -HaloTag-C2AB fusion construct and 2.5 mg of t-SNARE heterodimer were loaded as standards, and His 6 -HaloTag expressed without a fusion partner was used as a negative control.
Materials and Reagents
TTX, D-AP5, CNQX, picrotoxin, BAPTA-AM, and cyclopiazonic acid (CPA) were obtained from Abcam. Purified lipids used in biochemical assays were obtained from Avanti Polar Lipids. Cell culture reagents were supplied by GIBCO and Atlanta Biological. Unless otherwise noted, other chemical reagents were obtained from Sigma.
QUANTIFICATION AND STATISTICAL ANALYSIS
Values are reported, in both the text and figures, as mean ± standard error of the mean (SEM). For electrophysiological experiments, each ''n'' represents the measurement from a single cell or neuron and ''n's'' were obtained from at least three individual animal preparations. Other experimental designs indicate the definition of an ''n'' in the accompanying Results text or Figure Legend . Graphically, bars represent the mean value and error bars denoted the standard error. Unless otherwise noted, statistical analysis was conducted using a Student's t test when data were normally distributed. In the case of multiple comparisons, ANOVA tests were conducted and data were further analyzed with the appropriate post hoc test for the indicated individual comparisons (i.e., Tukey's test, Sidak's test, and Dunnett's multiple comparison test). For non-normally distributed datasets (assessed by D'Agostino-Pearson omnibus normality test), the nonparametric Mann-Whitney test (single comparison) or Kruskal-Wallis test (multiple comparisons) were used as appropriate. Expected sample sizes were not estimated or predetermined. All statistical analysis was conducted using GraphPad Prism 7.01 (GraphPad Software Inc).
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